Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...

Fatigue is a common problem for people with psoriatic arthritis. According to the National Psoriasis Foundation, some studies indicate that half of all psoriatic arthritis patients have ...

PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...

Dong-A ST's biosimilar product Imuldosa has been approved by the U.S. Food and Drug Administration (FDA), the Korean ...

Imuldose will be marketed in the United States by Accord BioPharma and is expected to launch in the first half of 2025.

Accord BioPharma receives US FDA approval for Imuldosa, a biosimilar to Stelara to treat chronic inflammatory conditions: Our Bureau, Mumbai Monday, October 14, 2024, 16:45 Hrs [I ...

Psoriatic arthritis is an inflammatory joint condition that is associated with the chronic skin condition psoriasis. The Arthritis Foundation says common symptoms of psoriatic arthritis include: ...

The Department of Work and Pensions already gives financial support to more than 1m people in the UK as a result of ...

More than 1.1 million adults across Great Britain are receiving support through PIP for musculoskeletal conditions, according ...

Tevogen Bio is a clinical-stage specialty immunotherapy biotech firm focusing on developing off-the-shelf, genetically unmodified T cell therapeutics aimed at treating both infectious diseases and ...

Daron Acemoglu, Simon Johnson and James Robinson won the 2024 Nobel economics prize "for studies of how institutions are formed and affect prosperity", the Royal Swedish Academy of Sciences said ...